These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33664598)
21. A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series. Schmit-Eilenberger VK Clin Ophthalmol; 2015; 9():801-11. PubMed ID: 25999689 [TBL] [Abstract][Full Text] [Related]
22. Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant. Meyer LM; Schönfeld CL Case Rep Ophthalmol; 2011 Sep; 2(3):319-22. PubMed ID: 22125533 [TBL] [Abstract][Full Text] [Related]
23. Challenging Clinical Cases - A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN Pessoa B; Melo-Beirão J; Meireles A; Menéres P Int Med Case Rep J; 2020; 13():437-448. PubMed ID: 32982484 [TBL] [Abstract][Full Text] [Related]
24. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients. Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512 [TBL] [Abstract][Full Text] [Related]
27. The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 Months. Roth DB; Eichenbaum D; Malik D; Radcliffe NM; Cutino A; Small KW; Ophthalmol Retina; 2024 Jan; 8(1):49-54. PubMed ID: 37586482 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness and tolerability of the fluocinolone acetonide implant in patients with diabetic macular edema in UAE: 12-Month results. Elbarky AM Eur J Ophthalmol; 2021 Nov; 31(6):3196-3202. PubMed ID: 33426902 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema. Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U; Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922 [TBL] [Abstract][Full Text] [Related]
31. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema. Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal dexamethasone implant for recurrent cystoid macular edema due to Irvine-Gass syndrome: a prospective case series. Sudhalkar A; Chhablani J; Vasavada A; Bhojwani D; Vasavada V; Vasavada S; Eye (Lond); 2016 Dec; 30(12):1549-1557. PubMed ID: 27858937 [TBL] [Abstract][Full Text] [Related]
33. Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials. Holden SE; Kapik B; Beiderbeck AB; Currie CJ Curr Med Res Opin; 2019 Jul; 35(7):1165-1176. PubMed ID: 30569759 [No Abstract] [Full Text] [Related]
34. INJECTABLE FLUOCINOLONE IMPLANT FOR THE MANAGEMENT OF CHRONIC POSTSURGICAL CYSTOID MACULAR EDEMA IN VITRECTOMIZED EYES. Patel KG; Flores J; Abbey AM Retina; 2023 Oct; 43(10):1732-1737. PubMed ID: 37267632 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome. Demirel S; Batioğlu F; Özmert E J Ocul Pharmacol Ther; 2012 Dec; 28(6):636-9. PubMed ID: 22731243 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy. Bajwa A; Aziz K; Foster CS Retina; 2014 Nov; 34(11):2259-68. PubMed ID: 24999722 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
38. Fluocinolone acetonide for the treatment of diabetic macular edema. Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565 [TBL] [Abstract][Full Text] [Related]
40. Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema. Currie CJ; Holden SE; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):33-43. PubMed ID: 28881150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]